Drug Pipeline

PGDM1400LS Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT06508749
The Tatelo Plus Study		 date change Primary completion moved earlier: 2027-11-05 -> 2027-09-03
2026-05-30 NCT06508749
The Tatelo Plus Study		 date change Completion moved earlier: 2028-04-21 -> 2028-02-18
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06812494 A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal… HIV Recruiting
Phase 1/2
NCT06508749 The Tatelo Plus Study HIV Recruiting
Phase 1
NCT07390955 A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult… HIV Recruiting
Sponsors Running PGDM1400LS Trials
National Institute of Allergy and Infectious Diseases (NIAID) (3)
Get alerts when PGDM1400LS trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free